This is why I was so excited when Ohm posited that
Post# of 148250
(Total Views: 577)
Posted On: 10/28/2021 6:47:12 PM
This is why I was so excited when Ohm posited that a future combo trial in cancer with checkpoint inhibitors might be 3-arms: LL with Keytruda or Opdivo, LL alone, placebo. How will they explain it if the LL arm is the same or even more effective than the combo arm but with no side effects?
Keytruda 2020 sales $4.2 Billion
Opdivo 2020 sales $7.9 Billion
GLTUA, Ganesha
Keytruda 2020 sales $4.2 Billion
Opdivo 2020 sales $7.9 Billion
GLTUA, Ganesha
(10)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼